Literature DB >> 31032687

What local experts expect from a health technology assessment (HTA) entity in Saudi Arabia: workshop conclusions.

Hussain Abdulrahman Al-Omar1,2, Abdulaziz Abdulhadi Attuwaijri3, Ibrahim Abdulrahman Aljuffali4,5.   

Abstract

Objectives: Saudi Arabia is undergoing a massive health-care transformation to fulfill its new, national 'Vision 2030.' To align with this objective, Saudi Arabia is establishing a new, independent and evidence-based health technology assessment (HTA) entity to help it maximizes health gains through efficient use of resources. This study was designed to ascertain how local experts perceive the creation of such a national HTA entity in Saudi Arabia; what they think about it and expect from it.
Methods: To achieve study aim, we held two workshops in Riyadh, Saudi Arabia, each lasting three and a half hours and each hosted by the Saudi Ministry of Health (MOH). We invited 26 local experts from a variety of professional backgrounds to discuss the establishment of a national HTA entity.
Results: The findings from experts workshops were structured around four axes, namely vision and remit; services provided and technologies covered; process and method; and implementation and practical considerations.
Conclusion: This paper discusses the findings of the local experts convened at the workshops relative to their expectations for and views about a national HTA entity within Saudi Arabia.

Keywords:  Health technology assessment; Saudi Arabia; Vision 2030; local experts; policy; strategy; workshop

Mesh:

Year:  2019        PMID: 31032687     DOI: 10.1080/14737167.2019.1610398

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN: 1473-7167            Impact factor:   2.217


  4 in total

Review 1.  Methodological Approaches to Cost-Effectiveness Analysis in Saudi Arabia: What Can We Learn? A Systematic Review.

Authors:  Fatma Maraiki; Shouki Bazarbashi; Paul Scuffham; Haitham Tuffaha
Journal:  MDM Policy Pract       Date:  2022-03-21

Review 2.  Improvement initiative in LDL-C management in Saudi Arabia: A call to action.

Authors:  Mirvat Alasnag; Zuhier Awan; Ahmed Al Ghamdi; Hind Al Modaimeigh; Mostafa Al Shemiri
Journal:  Int J Cardiol Heart Vasc       Date:  2020-10-27

3.  Pharmaceutical companies' views on a health technology assessment (HTA) entity in Saudi Arabia.

Authors:  Hussain Abdulrahman Al-Omar; Abdulaziz Abdulhadi Attuwaijri; Ibrahim Abdulrahman Aljuffali
Journal:  Saudi Pharm J       Date:  2020-04-23       Impact factor: 4.330

4.  Value drivers for pharmaceutical products in health technology assessment (HTA) in Saudi Arabia: Results from a capacity Building, Multi-Stakeholder workshop.

Authors:  Hussain A Al-Omar; Ibrahim A Aljuffali; Oriol Solà-Morales
Journal:  Saudi Pharm J       Date:  2021-08-04       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.